Muhammad Umar Waqqas
KARACHI: A nationwide campaign promoting vaccination against cervical cancer is currently underway, targeting young girls between the ages of nine and fourteen. The vaccine, designed to protect against the Human Papillomavirus (HPV), is being introduced as a preventive measure against cervical cancer, a disease widely associated with sexually transmitted infections.
While many health professionals strongly advocate for the vaccine, some experts are urging a broader and more critical discussion about its necessity, long-term benefits, and place within national health priorities.
Dr. Mariam Gul, a senior oncologist, has raised important questions that deserve thoughtful consideration. Cervical cancer is primarily linked to infection with the Human Papillomavirus (HPV), a virus transmitted through sexual contact. However, Dr. Gul asks whether mass vaccination at this stage is truly the most urgent health priority for young girls in our country.
“In a developing healthcare system with limited resources,” she notes, “we must carefully evaluate where our focus should lie.”
One of the concerns raised relates to coverage. The currently available HPV vaccines are designed to protect against only two major strains of the virus, though there are approximately a dozen strains known to be associated with cervical cancer. While these two strains are considered among the most high-risk, questions remain about the extent of protection against other cancer-causing types.
Another point of discussion is the duration of immunity. Available data suggests that the average protection period following vaccination is around six years. This raises further questions: Will booster doses be required? If so, will they be accessible and affordable? And who will bear the cost in the long term?
Dr. Gul also highlights a broader societal issue. In communities where malnutrition, limited access to education, and inadequate primary healthcare remain pressing challenges, should vaccination campaigns take precedence over nourishment and educational support for young girls?
“Health is holistic,” she emphasizes. “Proper nutrition, awareness, hygiene, and education are fundamental pillars of disease prevention.”
There is also the matter of public health responsibility. If vaccination is deemed essential, will the government ensure it is provided free of cost as part of national health policy? In many countries, HPV vaccination programs are state-funded to ensure equitable access. Without such guarantees, there is a risk that only families with financial means will benefit, potentially widening existing health disparities.
Supporters of the vaccine argue that prevention is always more cost-effective than treatment, particularly in the case of cancer. They maintain that even partial protection against high-risk HPV strains can significantly reduce cervical cancer rates over time.
However, as Dr. Mariam Gul suggests, the debate should not be framed as being “for” or “against” vaccination, but rather about priorities, sustainability, and comprehensive public health planning.
The conversation ultimately reflects a larger question facing many developing nations: how to balance preventive healthcare innovations with fundamental needs such as nutrition, education, and primary care infrastructure.
As the vaccination campaign progresses, transparent dialogue, evidence-based policy decisions, and public awareness will be essential to ensure that any intervention genuinely serves the long-term well-being of our young girls and society at large.
